Prevalence of Family History of Colorectal Cancer in the General Population
Overview
Affiliations
Background: Robust estimates of the prevalence of a family history of colorectal cancer in the general population are essential to inform planning of provision for colonoscopic surveillance and for clinical genetics services. However, there is a paucity of high-quality data.
Methods: Computerized record linkage was used to assess systematically the family history of 160 cancer-free community subjects and thereby provide prevalence data that are independent of participant recall. The data set comprised 2664 first- and second-degree relatives of study subjects, with 148 068 years at risk.
Results: Of people in the 30-70 years age range, 9.4 (95 per cent confidence interval (c.i.) 5.8 to 14.9) per cent had a first-degree relative affected by colorectal cancer, and 28.8 (95 per cent c.i. 22.3 to 36.2) per cent had an affected first- or second-degree relative. Between 0 and 3.1 per cent of study subjects merited colonic surveillance, depending on the stringency of the guidelines used.
Conclusion: An appreciable proportion of the general population has a relative affected by colorectal cancer, sufficient to merit screening under certain criteria. In the absence of good-quality evidence supporting colonoscopic surveillance in groups at moderate risk, these data directly inform the planning of services for people with a family history of colorectal cancer. However, the clinical risk and financial implications of screening should be taken into account.
Issaka R, Chan A, Gupta S Gastroenterology. 2023; 165(5):1280-1291.
PMID: 37737817 PMC: 10591903. DOI: 10.1053/j.gastro.2023.06.033.
Evidenced-Based Screening Strategies for a Positive Family History.
Kolb J, Ahnen D, Samadder N Gastrointest Endosc Clin N Am. 2020; 30(3):597-609.
PMID: 32439091 PMC: 7302941. DOI: 10.1016/j.giec.2020.02.015.
Gupta S, Bharti B, Ahnen D, Buchanan D, Cheng I, Cotterchio M Cancer. 2020; 126(13):3013-3020.
PMID: 32307706 PMC: 7702222. DOI: 10.1002/cncr.32851.
Monahan K, Bradshaw N, Dolwani S, DeSouza B, Dunlop M, East J Gut. 2019; 69(3):411-444.
PMID: 31780574 PMC: 7034349. DOI: 10.1136/gutjnl-2019-319915.
Lowery J, Ahnen D, Schroy 3rd P, Hampel H, Baxter N, Boland C Cancer. 2016; 122(17):2633-45.
PMID: 27258162 PMC: 5575812. DOI: 10.1002/cncr.30080.